Standard Biotools | FLDM - Operating Expenses


Standard Biotools reported $30.56M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Illumina USD 852M 51M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Nikon Corporation JPY 202.07B 67.73B Mar/2026
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Revvity USD 628.34M 2.12M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sony JPY 2.81T 396.47B Mar/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 1.12B 457.15M Mar/2026